Ahmed M El Kerdawy

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Advanced Non Small Cell Lung Cancer

Molecular Docking

Top Venues

Journal of molecular modeling

Drug design, development and therapy

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Tarfah Al-Warhi, Ahmed M El Kerdawy, Mohamed Adel Said, Amgad Albohy, Zainab M Elsayed, Nada Aljaeed, Eslam B Elkaeed, Wagdy M Eldehna, Hatem A Abdel-Aziz, Miral A Abdelmoaz
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Drug design, development and therapy 16 (2022)
Tarfah Al-Warhi, Ahmed M El Kerdawy, Nada Aljaeed, Omnia E Ismael, Rezk R Ayyad, Wagdy M Eldehna, Hatem A Abdel-Aziz, Ghada H Al-Ansary
Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors. Molecules (Basel, Switzerland) 25 (9) (2020)
Ahmed M El Kerdawy, Alaa A Osman, Marwa A Zaater
Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors. Journal of molecular modeling 25 (6) (2019)